Cutaneous Melanoma
📧 Sign up to get email alerts when something new happens for Cutaneous Melanoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-09Clinical Trial Update: Pembrolizumab and Stereotactic Radiosurgery for Melanoma or Non-Small Cell Lung Cancer Brain Metastases [Phase 1]
This phase 1 study assessed pembrolizumab in combination with stereotactic radiosurgery for patients with brain metastases from melanoma or …
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome
An ongoing clinical trial is recruiting to study the frequency and clinical phenotype of BAP1 tumor predisposition syndrome and its associat…
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: Neoadjuvant Atezolizumab in Cutaneous Melanoma [Phase 1]
Phase 1 neoadjuvant trial of atezolizumab in patients with cutaneous melanoma; the study is currently ACTIVE_NOT_RECRUITING.
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Stereotactic Radiosurgery in Treating Patients With Greater Than 3 Melanoma Brain Metastases [Phase 2]
Phase 2 trial evaluating stereotactic radiosurgery for patients with more than three melanoma brain metastases; the study is currently activ…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: PRAME Immunohistochemistry-Guided Slow Mohs Micrographic Surgery for the Treatment of Stage 0 to IIc Cutaneous Melanoma [NA]
An ongoing UC Davis-sponsored clinical trial is evaluating PRAME immunohistochemistry-guided slow Mohs micrographic surgery for stage 0 to I…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: Safety and Preliminary Efficacy of MBS8(1V270) in Cancer Patients With Advanced Solid Tumours [Phase 1]
Phase 1 study of the investigational therapy MBS8(1V270) evaluating safety and preliminary efficacy in patients with advanced solid tumors, …
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: 177Lu-anti-PD-L1 sdAb in Metastatic Solid Tumors [EARLY_Phase 1]
Early-phase clinical trial investigating a radiolabeled anti-PD-L1 single-domain antibody (177Lu-anti-PD-L1 sdAb) in metastatic solid tumors…
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: Neo IRENIE (NEOadjuvant Ipilimumab, RElatlimab, NIvolumab Evaluation) [Phase 2]
A Phase 2 neoadjuvant trial (Neo IRENIE) evaluating a triple combination of ipilimumab, relatlimab, and nivolumab in resectable cutaneous an…
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: Electrochemotherapy-Induced Changes in Tumor Microenvironment in Cutaneous Melanoma [NA]
This clinical trial investigates how electrochemotherapy alters the tumor microenvironment in cutaneous melanoma, with recruitment ongoing. …
-
CLINICAL_TRIALS trial_result · 2026-02-18Clinical Trial Update: Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma [Phase 3]
Phase 3 clinical trial evaluating two sequencing strategies for BRAFV600-mutant stage III–IV melanoma: dabrafenib plus trametinib followed b…
-
CLINICAL_TRIALS trial_result · 2026-02-13Clinical Trial Update: Dabrafenib and Trametinib Before and After Surgery in Treating Patients With Stage IIIB-C Melanoma With BRAF V600 Mutation [Phase 2]
A Phase 2 clinical trial evaluating dabrafenib plus trametinib given before and after surgery in patients with stage IIIB-C cutaneous melano…
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: Study of RP1 Monotherapy and RP1 in Combination With Nivolumab (IGNYTE) [Phase 2]
Clinical trial update for RP1 as a monotherapy and in combination with nivolumab (IGNYTE) in Phase 2 across several cancers; the study is cu…
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: Neo-adjuvant Immunotherapy in Patients With Localized Melanoma [Phase 2]
Phase 2 clinical trial update on neo-adjuvant immunotherapy for localized melanoma, currently recruiting.
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: Exercise to Boost Response to Checkpoint Blockade Immunotherapy [EARLY_Phase 1]
This clinical trial update describes an Early Phase 1 study at H. Lee Moffitt Cancer Center examining whether exercise can boost responses t…
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: A Phase 2 Clinical Trial of Neoadjuvant Relatlimab and Nivolumab in High Risk, Clinical Stage II Cutaneous Melanoma [Phase 2]
Phase 2 neoadjuvant trial of relatlimab plus nivolumab in high-risk clinical stage II cutaneous melanoma; the study is currently active and …
-
CLINICAL_TRIALS trial_result · 2026-01-28Clinical Trial Update: Modified Virus VSV-IFNbetaTYRP1 in Treating Patients With Stage III-IV Melanoma [Phase 1]
Phase 1 trial of the modified virus VSV-IFNbetaTYRP1 in stage III-IV melanoma was terminated.
-
CLINICAL_TRIALS research · 2026-01-27Clinical Trial Update: Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions [Phase 1, Phase 2]
A Phase 1/2 study evaluating darovasertib (IDE196), a PKC inhibitor, in patients with solid tumors harboring GNAQ/GNA11 mutations or PRKC fu…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: COmparison of the Use of a PERforator Flap Versus Total Skin GRAft in the Management of Loss of Substance After Resection of Cutaneous Melanoma - Pilot Study
This clinical trial registry entry outlines a pilot study comparing perforator flap reconstruction versus total skin grafting for managing t…
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: Natural Killer Cell Therapy (UD TGFbetai NK Cells) and Temozolomide for the Treatment of Stage IV Melanoma Metastatic to the Brain [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating natural killer cell therapy (UD TGFβi NK cells) in combination with temozolomide for patients with …
-
CLINICAL_TRIALS trial_result · 2026-01-06Clinical Trial Update: A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced Cancers [Phase 1]
Phase 1 study assessing safety and early efficacy of KFA115 alone and in combination with pembrolizumab in select advanced cancers; the tria…
-
CLINICAL_TRIALS research · 2025-12-30Clinical Trial Update: Vemurafenib, Cobimetinib, Atezolizumab, and Tiragolumab in Treating Patients With High-Risk Stage III Melanoma [Phase 2]
Phase 2 trial update evaluating a four-drug combination (vemurafenib, cobimetinib, atezolizumab, and tiragolumab) for high-risk stage III cu…
-
CLINICAL_TRIALS research · 2025-12-26Clinical Trial Update: Observational Basket Trial to Collect Tissue to Develop and Train a Live Tumor Diagnostic Platform
An observational basket trial sponsored by Elephas aims to collect tissue to develop and train a live tumor diagnostic platform across multi…
-
CLINICAL_TRIALS trial_result · 2025-12-08Clinical Trial Update: Enhancing Skin Cancer Early Detection and Treatment in Primary Care [NA]
A completed clinical trial focused on improving early detection and treatment of cutaneous melanoma in primary care settings. The study resu…
-
CLINICAL_TRIALS research · 2025-12-04Clinical Trial Update: Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program [Phase 2]
Phase 2 trial evaluating in-home versus in-clinic subcutaneous nivolumab administration under the CC Beyond Walls program; the study is curr…
-
CLINICAL_TRIALS research · 2025-12-03Clinical Trial Update: Clear Me: Interception Trial to Detect and Clear Molecular Residual Disease in Patients With High-risk Melanoma [Phase 2]
A Phase 2 trial named Clear Me aims to detect and clear molecular residual disease in high-risk melanoma and is currently recruiting, includ…